The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hanlon Susan M since 2005.
The trader's CIK number is 1221862.
At the time of the last reporting, Hanlon Susan M was the VP Finance of Haemonetics Corp. (stock ticker symbol HAE).
Also see all insider trading activities at Haemonetics Corp.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | HAE | 0 | $0 | 17,659 | $743,666 | 17,000 | $456,140 |
2014 | HAE | 0 | $0 | 10,896 | $434,118 | 10,896 | $294,217 |
2013 | HAE | 245 | $8,017 | 18,326 | $772,783 | 17,138 | $312,798 |
2012 | HAE | 263 | $14,488 | 15,282 | $1,110,271 | 15,282 | $670,334 |
2011 | HAE | 285 | $14,023 | 3,000 | $195,000 | 3,000 | $91,155 |
2010 | HAE | 311 | $14,314 | 3,500 | $213,465 | 3,500 | $106,347 |
2009 | HAE | 307 | $13,510 | 3,145 | $196,884 | 3,000 | $91,155 |
2008 | HAE | 283 | $12,708 | 68 | $3,638 | 0 | $0 |
2007 | HAE | 285 | $11,292 | 0 | $0 | 0 | $0 |
2006 | HAE | 253 | $10,117 | 0 | $0 | 0 | $0 |
2005 | HAE | 166 | $4,515 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-10-26 | HAE | Sale | 497 | 32.13 | 15,968 |
2015-10-23 | HAE | Sale | 162 | 31.75 | 5,143 |
2015-06-10 | HAE | Option Ex | 6,000 | 27.50 | 164,970 |
2015-06-10 | HAE | Sale | 6,000 | 43.00 | 258,000 |
2015-05-05 | HAE | Sale | 4,000 | 40.08 | 160,300 |
2015-05-05 | HAE | Option Ex | 4,000 | 26.47 | 105,880 |
2015-03-27 | HAE | Sale | 7,000 | 43.47 | 304,255 |
2015-03-27 | HAE | Option Ex | 7,000 | 26.47 | 185,290 |
2014-02-18 | HAE | Option Ex | 3,690 | 26.47 | 97,674 |
2014-02-18 | HAE | Sale | 3,690 | 39.00 | 143,910 |
2014-01-27 | HAE | Sale | 3,206 | 38.37 | 123,020 |
2014-01-27 | HAE | Option Ex | 3,206 | 27.27 | 87,443 |
2014-01-10 | HAE | Sale | 4,000 | 41.80 | 167,188 |
2014-01-10 | HAE | Option Ex | 4,000 | 27.27 | 109,100 |
2013-12-16 | HAE | Sale | 4,000 | 43.49 | 173,980 |
2013-12-16 | HAE | Option Ex | 4,000 | 25.54 | 102,140 |
2013-12-09 | HAE | Option Ex | 3,138 | 25.54 | 80,128 |
2013-12-09 | HAE | Sale | 3,138 | 43.07 | 135,166 |
2013-11-13 | HAE | Sale | 1,188 | 39.62 | 47,068 |
2013-04-30 | HAE | Buy | 245 | 32.73 | 8,017 |
2013-01-04 | HAE | Option Ex | 10,000 | 13.05 | 130,530 |
2013-01-04 | HAE | Sale | 10,000 | 41.66 | 416,569 |
2012-11-01 | HAE | Buy | 119 | 61.45 | 7,313 |
2012-07-09 | HAE | Option Ex | 7,282 | 52.76 | 384,198 |
2012-07-09 | HAE | Sale | 7,282 | 73.98 | 538,751 |
2012-05-03 | HAE | Option Ex | 8,000 | 35.77 | 286,136 |
2012-05-03 | HAE | Sale | 8,000 | 71.44 | 571,520 |
2012-05-01 | HAE | Buy | 144 | 49.83 | 7,175 |
2011-11-03 | HAE | Buy | 137 | 51.81 | 7,097 |
2011-05-04 | HAE | Buy | 148 | 46.80 | 6,926 |
2011-03-30 | HAE | Option Ex | 3,000 | 30.39 | 91,155 |
2011-03-30 | HAE | Sale | 3,000 | 65.00 | 195,000 |
2010-12-06 | HAE | Sale | 3,500 | 60.99 | 213,465 |
2010-12-06 | HAE | Option Ex | 3,500 | 30.39 | 106,347 |
2010-11-04 | HAE | Buy | 160 | 46.34 | 7,413 |
2010-04-30 | HAE | Buy | 151 | 45.70 | 6,901 |
2009-10-30 | HAE | Buy | 155 | 44.13 | 6,840 |
2009-10-26 | HAE | Sale | 72 | 54.52 | 3,925 |
2009-10-23 | HAE | Sale | 73 | 54.24 | 3,959 |
2009-05-01 | HAE | Buy | 152 | 43.89 | 6,670 |
2009-02-02 | HAE | Option Ex | 3,000 | 30.39 | 91,155 |
2009-02-02 | HAE | Sale | 3,000 | 63.00 | 189,000 |
2008-10-31 | HAE | Buy | 145 | 45.44 | 6,588 |
2008-10-28 | HAE | Sale | 68 | 53.50 | 3,638 |
2008-05-01 | HAE | Buy | 138 | 44.35 | 6,120 |
2007-11-01 | HAE | Buy | 139 | 40.66 | 5,652 |
2007-05-01 | HAE | Buy | 146 | 38.63 | 5,640 |
2006-11-01 | HAE | Buy | 140 | 38.76 | 5,426 |
2006-05-01 | HAE | Buy | 113 | 41.52 | 4,691 |
2005-05-02 | HAE | Buy | 166 | 27.20 | 4,515 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hanlon Susan M (VP Finance of Haemonetics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.